Cancer Discovery, pages OF1-OF16

Identification of Clonal Hematopoiesis Driver Mutations through In Silico Saturation Mutagenesis

S. Demajo 1, 2, 3
Joan Enric Ramis Zaldivar 2, 3, 4
Ferran Muiños 2, 3, 4
Miguel L. Grau 2, 4
Maria A Andrianova 2, 4
Nuria Lopez-Bigas 2, 3, 4, 5, 6
Abel Gonzalez-Perez 2, 3, 4, 6
1
 
IRB Barcelona, Barcelona, Spain
3
 
Centro de Investigación Biomédica en Red en Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain. 2
4
 
Institute for Research in Biomedicine, Barcelona, Spain
5
 
Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. 3
6
 
University Pompeu Fabra, Barcelona, Spain. 4
Publication typeJournal Article
Publication date2024-07-09
Journal: Cancer Discovery
scimago Q1
SJR7.533
CiteScore22.9
Impact factor29.7
ISSN21598274, 21598290
Abstract

Clonal hematopoiesis (CH) is a phenomenon of clonal expansion of hematopoietic stem cells driven by somatic mutations affecting certain genes. Recently, CH has been linked to the development of hematologic malignancies, cardiovascular diseases, and other conditions. Although the most frequently mutated CH driver genes have been identified, a systematic landscape of the mutations capable of initiating this phenomenon is still lacking. In this study, we trained machine learning models for 12 of the most recurrent CH genes to identify their driver mutations. These models outperform expert-curated rules based on prior knowledge of the function of these genes. Moreover, their application to identify CH driver mutations across almost half a million donors of the UK Biobank reproduces known associations between CH driver mutations and age, and the prevalence of several diseases and conditions. We thus propose that these models support the accurate identification of CH across healthy individuals.

Significance: We developed and validated gene-specific machine learning models to identify CH driver mutations, showing their advantage with respect to expert-curated rules. These models can support the identification and clinical interpretation of CH mutations in newly sequenced individuals.

Found 

Top-30

Journals

1
1

Publishers

1
1
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST | RIS | BibTex
Found error?